Nicardipine HCl

Nicardipine HCl__L-type Ca channel blocker lumateperone (Tosylate)

Product Name Nicardipine HCl
Description

L-type Ca channel blocker

Purity >98%
CAS No. 54527-84-3
Molecular Formula C26H29N3O6•HCl
Molecular Weight 515.99
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO (1 mg/ml), ethanol:water 25:75-70:30, propylene glycol, or methanol; slightly soluble in acetone, 100% ethanol, chloroform and water.
Source Synthetic
Appearance Yellow solid
SMILES CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)N+(=O)O-)C(=O)OC.Cl
InChI InChI=1S/C26H29N3O6.ClH/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19;/h5-12,15,24,27H,13-14,16H2,1-4H3;1H
InChIKey AIKVCUNQWYTVTO-UHFFFAOYSA-N
Safety Phrases Classification: Toxic. May be harmful or fatal if inhaled, swallowed or absorbed through skin.
Safety Phrases:
S22 – Do not breathe dust
S24/25 – Avoid contact with skin and eyes
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S45- In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
Risk Phrases:
R23/24/25- Toxic by inhalation, if swallowed and in contact with skin.
Hazard Phrases:
H301-H311-H331
Precautionary Phrases:
P261-P280-P301 + P310-P311
Cite This Product Nicardipine HCl (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-313)
Alternative Names 2-Benzyl(methyl)aminoethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate hydrochloride (1:1)
Research Areas Calcium Channels, Ion Channels, Neuroscience, Voltage-Gated Calcium Channels
PubChem ID 41114
Scientific Background Nicardipine is a dihydropyridine calcium-channel blocking agent used for the treatment of vascular disorders such as chronic stable angina, hyptertension and Raynaud’s phenomenon. Its mechanism of acion is to inhibit the transmembrane influx of calcium ions into the cardiac muscle and smooth muscle without changing the serum calcium concentrations.
References 1. Huang R.I., et al. (2006) Catheter Cardiovasc Interv. 68(5): 671-676.